A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer

• Main Authors: Suenaga M (Author), Mizunuma N (Author), Matsusaka S (Author), Shinozaki E (Author), Ozaka M (Author), Ogura M (Author), Chin K (Author), Yamaguchi T (Author)
• Format: Book
• Published: Dove Medical Press, 2015-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Mitsukuni Suenaga,1 Nobuyuki Mizunuma,1 Satoshi Matsusaka,1 Eiji Shinozaki,1 Masato Ozaka,1 Mariko Ogura,1 Keisho Chin,1 Toshiharu Yamaguchi2 1Department of Gastroenterology, 2Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Res...